• New findings could benefit patients with triple-negative breast cancer

    2 monthes ago - By News Medical

    About 15 percent of breast cancers are classified as triple-negative, lacking receptors for estrogen, progesterone, and Her2.
    Read more ...

     

  • Study shows no added benefit of pertuzumab combination in treatment of early breast cancer

    2 monthes ago - By News Medical

    For the third time since 2013, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment the added benefit of the drug pertuzumab in the treatment of HER2-positive breast cancer.
    Read more ...

     

  • Many breast cancer patients share and discuss their experiences on Twitter, study finds

    2 monthes ago - By News Medical

    Twitter is a place where many cancer patients go to share and discuss their experiences of the disease. This is the main finding of a recent exploratory study (1), to be presented at the ESMO 2018 Congress in Munich, which analyzed the contents of over 6,000 tweets and retweets about breast cancer.
    Read more ...